BALDI, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 1.703
EU - Europa 486
AS - Asia 311
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.511
Nazione #
US - Stati Uniti d'America 1.700
CN - Cina 182
IT - Italia 163
UA - Ucraina 94
GB - Regno Unito 65
TR - Turchia 64
DE - Germania 58
SG - Singapore 35
SE - Svezia 30
FI - Finlandia 27
BE - Belgio 17
HK - Hong Kong 10
ID - Indonesia 8
CZ - Repubblica Ceca 7
FR - Francia 7
AT - Austria 5
AU - Australia 4
IR - Iran 4
PE - Perù 4
PL - Polonia 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
NL - Olanda 3
CA - Canada 2
HU - Ungheria 2
IQ - Iraq 2
ES - Italia 1
HN - Honduras 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
RO - Romania 1
Totale 2.511
Città #
Woodbridge 236
Fairfield 182
Chandler 161
Ashburn 132
Ann Arbor 131
Houston 128
Jacksonville 110
Ferrara 69
Wilmington 58
Cambridge 57
Seattle 53
Milan 41
Nanjing 41
Izmir 40
New York 36
Princeton 32
Beijing 31
Boardman 29
Dearborn 29
Shanghai 27
Singapore 22
Addison 21
Brussels 17
San Diego 15
Nanchang 14
Bremen 12
Shenyang 12
Hong Kong 10
Jiaxing 9
Los Angeles 9
Jakarta 8
Norwalk 8
Bologna 7
Brno 7
Jinan 7
Auburn Hills 6
Changsha 6
Hebei 6
Tianjin 6
Des Moines 5
Redwood City 5
San Mateo 5
Vienna 5
Washington 5
Guangzhou 4
Lima 4
Ningbo 4
Warsaw 4
Augusta 3
Dong Ket 3
Indiana 3
Kunming 3
Leawood 3
London 3
Mountain View 3
Redmond 3
Rome 3
Sant'elena 3
Udine 3
Ardabil 2
Chicago 2
Győr 2
Hangzhou 2
Harringay 2
Lanzhou 2
Naples 2
Orange 2
Philadelphia 2
Poggio Renatico 2
Roncoferraro 2
Tappahannock 2
Amsterdam 1
Ankara 1
Baotou 1
Changchun 1
Cormeilles-en-Parisis 1
Dublin 1
Exeter 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Hanoi 1
Harbin 1
Hefei 1
Helsinki 1
Hounslow 1
Hull 1
Kilburn 1
Madrid 1
Mezzolombardo 1
Odesa 1
Pescara 1
Quzhou 1
San Pedro Sula 1
Schiphol 1
Shaoxing 1
Simi Valley 1
Tokyo 1
Toronto 1
Utrecht 1
Villa Guardia 1
Totale 1.952
Nome #
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 140
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 130
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 130
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 123
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 122
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 118
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 116
Epidemiological health and social study on multiple sclerosis in the Ferrara province 114
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 107
null 104
null 90
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 88
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 85
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 81
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 75
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 75
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 70
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 69
null 66
null 66
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 63
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 62
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 60
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 58
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 57
null 45
MMP-9 isoforms in serum of Multiple Sclerosis patients 42
Smaller optic nerve diameters and reduced flow velocity of ophthalmic artery suggest a history of optic neuritides: Transorbital Ultrasonography and Doppler Ultrasound in multiple sclerosis 38
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 34
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 29
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 27
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 24
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study 21
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study 14
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS 10
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 10
Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. 6
Totale 2.569
Categoria #
all - tutte 10.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 82 18 22 57 27 59 60 56 39 50 16 9
2020/2021298 21 22 11 31 16 33 8 31 14 41 47 23
2021/2022290 8 36 23 5 15 11 14 14 13 25 24 102
2022/2023381 34 44 9 58 56 41 27 37 33 5 22 15
2023/2024312 23 15 9 4 37 50 19 34 17 18 22 64
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 2.569